Clinical Trials on Secondary Cancer

Total 52755 results

Repros Therapeutics Inc.

Completed

Normalization of Morning Testosterone Levels in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Safety Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

An Extension Study of Enclomiphene Citrate in the Treatment of Men With Secondary Hypogonadism

Secondary Hypogonadism
Amgen

Completed

Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing Hemodialysis

Hyperparathyroidism, Secondary
KAI Pharmaceuticals

Completed

Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary Hyperparathyroidism

Hyperparathyroidism, Secondary

United States, Australia
Repros Therapeutics Inc.

Completed

The Effect on Androxal Versus Androgel on Morning Testosterone in Men With Secondary Hypogonadism (Low Testosterone)

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Androxal™ Treatment in Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
University of California, San Francisco
Foundation for Physical Therapy, Inc.

Completed

Treatment of Breast Cancer-related Lymphedema With a Negative Pressure Device

Lymphedema of Upper Limb | Lymphedema, Secondary

United States
OPKO Health, Inc.

Completed

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

Vitamin D Insufficiency | CKD Stage 4 | CKD Stage 3 | Secondary Hyperparathyroidism Due to Renal Causes

United States
Azienda Ospedaliero Universitaria Maggiore della...

Unknown

Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions

Lung Cancer | Secondary Lung Cancer | Benign Lung Lesions

Italy
Université Catholique de Louvain

Completed

Reliability of Measuring the Area and Intensity of Secondary Hyperalgesia Induced by High Frequency Stimulation

Hyperalgesia, Secondary

Belgium
The Second Hospital of Anhui Medical University

Unknown

Comparison of Total Parathyroidectomy With and Without Autotransplantation

Secondary Hyperparathyroidism

China
Radboud University Medical Center

Completed

Effectiveness of Adhesive Containing MDPB

Secondary Caries
University Hospital, Linkoeping

Completed

Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects ((RAV))

Edema Secondary

Sweden
Hospices Civils de Lyon

Recruiting

PITCHER (Peritoneal Carcinomatosis Heterogeneity)

Colorectal Cancer | Ovarian Cancer | Secondary Peritoneal Cancers

France
Herantis Pharma Plc.

Active, not recruiting

Clinical Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (AdeLE) (AdeLE)

Secondary Lymphedema

Finland, Sweden
Herantis Pharma Plc.

Terminated

A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema

Secondary Lymphedema

Finland
State University of New York at Buffalo

Completed

The Effect of Botulinum Toxin A on Headache Attributed to TMD

Secondary Headache Disorder

United States
Poznan University of Medical Sciences

Completed

ICF in Secondary Prevention of Cardiovascular Disease

Cardiovascular Diseases | Risk Factor, Cardiovascular | Secondary Prevention

Poland
Repros Therapeutics Inc.

Completed

To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone

Secondary Hypogonadism

United States
Repros Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Androxal Treatment in Men With Secondary Hypogonadism (ZA-003Ext)

Secondary Hypogonadism

United States
Institute of Hematology & Blood Diseases Hospital

Not yet recruiting

Secondary Prophylaxis of CMV Infection Using Letermovir After HID-HSCT

To Evaluate the Efficacy and Safety of Secondary Prophylaxis of CMV Reactivation
University Ghent

Completed

Dose Titration of Lisinopril in Children Aged 1 to 18 Years With Primary or Secondary Hypertension (Lisi-ped)

Primary Hypertension | Secondary Hypertension

Belgium
Mansoura University

Completed

A 2-year Clinical Performance of Two Different Ion-releasing Bulk-fill Restorative Materials Posterior Cavities

Secondary Caries

Egypt
OPKO Health, Inc.

Withdrawn

Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) (2007)

Secondary Hyperparathyroidism (SHPT) | Stage 5 Chronic Kidney Disease (CKD) | Hemodialysis (HD)
Boehringer Ingelheim

Completed

Safety of Dabigatran Etexilate in Blood Clot Prevention in Children

Venous Thromboembolism | Secondary Prevention

United States, Norway, Canada, Belgium, Thailand, Italy, Germany, Turkey, Austria, Hungary, Czechia, Taiwan, Israel, Brazil, Denmark, France, Lithuania, Mexico, Russian Federation, Sweden, Switzerland, Ukraine
Rigshospitalet, Denmark

Completed

Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment Method

Measurements of Areas of Secondary Hyperalgesia
Repros Therapeutics Inc.

Completed

Phase III Study to Evaluate Morning Testosterone Normalization in Overweight Men With Secondary Hypogonadism

Secondary Hypogonadism

United States
Amgen

Completed

Study for Secondary Hyperparathyroidism in Chronic Renal Insufficiency Patients

Secondary Hyperparathyroidism | Chronic Renal Insufficiency
BioMS Technology Corp.

Terminated

Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis (MAESTRO-03)

Multiple Sclerosis, Secondary Progressive
University Hospital, Ghent
Novus Scientific

Completed

Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh. (TIGR)

Primary and Secondary Ventral Hernia

United Kingdom, Belgium, Denmark, Poland, Spain
UCB Pharma

Completed

A Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel Group Trial to Investigate the Efficacy and Safety of SPM 927 (200mg/Day and 400mg/Day) as Adjunctive Therapy in Subjects With Partial Seizures With or Without Secondary Generalization

Partial Seizures With or Without Secondary Generalization

Germany
Chinese University of Hong Kong

Completed

Cincalcet and Vascular Arterial Stiffness Among Peritoneal Dialysis Patients With Secondary Hyperparathyroidism

Hyperparathyroidism | Arterial Stiffness

Hong Kong
Amgen

Completed

A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416

Secondary Hyperparathyroidism

China
Ain Shams University

Completed

Neuroablation Versus Neuromodulation Techniques for Treatment of Secondary Dystonia

Secondary Dystonia
Genzyme, a Sanofi Company

Completed

A Phase 4 Pharmacokinetic Study of Hectorol Injection and Zemplar Injection in CKD Subjects on Hemodialysis

Secondary Hyperparathyroidism

United States
Soonchunhyang University Hospital
Seoul National University Hospital; SMG-SNU Boramae Medical Center; Saint Vincent... and other collaborators

Recruiting

Abscopal Effect From the Low-dose Radiotherapy in Polymetastatic Cancer Patients Receiving Stereotactic Radiotherapy (KROG22-11)

Neoplasms | Secondary Malignant Neoplasm

Korea, Republic of
Amgen

Completed

Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)

Chronic Kidney Disease | Secondary Hyperparathyroidism

Korea, Republic of, Taiwan, Hong Kong, China, India, Malaysia
Amgen

Completed

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary

United States, Germany, United Kingdom
Benha University
New Jeddah Clinic Hospital

Completed

Prevalence of Secondary Hyperparathyroidism Among Patients With Diabetic Nephropathy

Diabetic Nephropathies | Secondary Hyperparathyroidism
The University of Hong Kong
AbbVie

Unknown

Intravenous Paricalcitol in Chronic Hemodialysis Patients

Secondary Hyperparathyroidism | Endstage Renal Disease

Hong Kong
Abbott

Completed

Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin D (IMPACT SHPT)

Hemodialysis | Chronic Kidney Disease | Secondary Hyperparathyroidism

United States, Czech Republic, Denmark, Germany, Greece, Italy, Netherlands, Portugal, Russian Federation, Spain, Sweden, United Kingdom
ENRICO VERRINA

Unknown

Cinacalcet in Paediatric Secondary Hyperparathyroidism (SHPT) Due to Chronic Kidney Disease (CKD)

Secondary Hyperparathyroidism

Italy
Abbott

Completed

Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary Hyperparathyroidism

Hemodialysis | Secondary Hyperparathyroidism

Japan
Universitaire Ziekenhuizen KU Leuven

Completed

Comparison of Multigam IV (5% vs. 10%) in Patients With an Immunodeficiency Secondary to a Hematological Disorder (MULTISIM)

Hematologic Diseases | Secondary Immune Deficiency

Belgium
St. Franziskus Hospital
University of Erlangen-Nürnberg Medical School

Completed

Ultrastructural Changes of Trabeculectomy Specimens in Patients With Uveitic Secondary Glaucoma

Uveitis | Secondary Glaucoma

Germany
Smith & Nephew Orthopaedics AG

Completed

Multicenter Clinical Observation PROMOS®

Primary and Secondary Omarthrosis
First Affiliated Hospital of Chengdu Medical College

Recruiting

Comparison of Catecholamine Concentrations in Venous Blood During Selective Adrenal Artery Embolization

Primary Aldosteronism | Resistant Hypertension | Secondary Hypertension | Secondary Hypertension to Endocrine Disorders

China
Chengdu Suncadia Medicine Co., Ltd.

Not yet recruiting

A Study to Assess the Efficacy and Safety of Paricalcitol in the Treatment of Chronic Kidney Disease With Secondary Hyperparathyroidism

Secondary Hyperparathyroidism
Amgen

Completed

20070360 Incident Dialysis

Chronic Kidney Disease | Secondary Hyperparathyroidism

Clinical Trials on Secondary Cancer

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations